User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

5632

Interactions with Platform & by Email *

INTERACTIONS

901

Unique # Participated *

PARTICIPANTS

169

Responses Validated *

VALIDATIONS

37

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Glucosamine: The Leading Dietary Supplement in the Joint Health Market.....II-4
Global Market Analysis.....II-4
2$125
   Market Trends.....II-6
Nutritional Supplements Industry Remains Resilient to Economic Downturn.....II-6
Aging Population Drives Glucosamine Market.....II-6
Table 1: Worldwide Distribution of 65+ Population by Region/Country: As on July 2009 (includes corresponding Graph/Chart).....II-6
1$350
   China Races Ahead in Glucosamine Production and Supply Worldwide.....II-7
Newer Formulations of Glucosamine Being Introduced.....II-7
Glucosamine Fortification: An Emerging Trend.....II-7
1$100
   Table 2: Glucosamine Product Launches by Region (2006-2009): Asia-Pacific, North America, and Europe (includes corresponding Graph/Chart).....II-8
Plant-Derived Glucosamine Gains Popularity.....II-8
1$350
   Combination Supplements: A Double Whammy Success.....II-9
Select Combination Supplements At a Glance.....II-9
1$100
   Functional Food and Beverages: Promising End-Market for Glucosamine.....II-10
Alternative Joint Health Ingredients May Have an Impact on Future Sales.....II-10
1$100
   Glucosamine and the Benefits Offered.....II-11
Why Glucosamine Supplements?.....II-11
Chitin and Chitosan: A Prelude.....II-11
1$100
   Manufacturing of Glucosamine.....II-12
Forms of Glucosamine.....II-12
Glucosamine Sulfate Takes the Front Seat.....II-12
Glucosamine Hydrochloride: Efficacy Still Doubted.....II-12
1$100
   Glucosamine and Recommended Dose.....II-13
Glucosamine Interactions.....II-13
Combo Power: Glucosamine Plus Other Ingredients.....II-13
Diverse Views on Glucosamine/Chondroitin Use for Osteoarthritis Treatment.....II-13
1$100
   CosaminDS Ranked No.1.....II-14
Shifting Preferences Towards Glucosamine Plus MSM Supplement.....II-14
Glucosamine and Omega-3 Fatty Acids: A New Combination.....II-14
Select Glucosamine Supplements Available in the Market – A Review.....II-14
Oral Glucosamine.....II-14
Osteo Bi-Flex® (NBTY, Inc.).....II-14
1$100
   Move Free® Advanced (Schiff Nutrition Group, Inc.).....II-15
Cosamin® DS (Nutramax Laboratories, Inc).....II-15
TripleFlex® (Pharmavite LLC).....II-15
1$100
   Vegetarian Glucosamine.....II-16
Regenasure® (Cargill).....II-16
Regenasure Applications by Select Country.....II-16
JointAstin (Cyanotech).....II-16
Liquid Vegetarian Glucosamine/MSM (Trace Minerals Research).....II-16
1$100
   Avoca® ASU (Nutramax Laboratories, Inc.).....II-17
GlucosaGreen (Hygieia Health).....II-17
GreenGrown glucosamine (Ethical Naturals, Inc.).....II-17
Liquid Glucosamine.....II-17
Major Liquid Glucosamine Brands.....II-17
1$100
   Topical Glucosamine Still Inferior Over Other Formulations.....II-18
Urah™ TGC: A Topical Glucosamine Brand.....II-18
1$100
   High Doses of Glucosamine Supplements Can Increase Diabetes Risk.....II-19
Zero Adverse Affects of Oral Glucosamine on Glucose Metabolism.....II-19
Glucosamine Fails to Relieve Lower Back Pain.....II-19
Positive Affects of Glucosamine Sulfate and Omega-3 Combo on Joint Health.....II-19
1$100
   Eggshell Membrane Outweighs Glucosamine for Joint Health Under ESM Funded Clinical
  Trial.....II-20
Prolonged Use of High Purity and Concentrated Chondroitin Sulphate May Avoid Joint
  Degradation.....II-20
InterHealth’s Patented Collagen Ingredient Outperforms Glucosamine and Chondroitin for
  Joint Health.....II-20
Glucosamine to Treat UV- Related Skin Damage.....II-20
1$100
   Glucosamine Feared to Affect Fertility.....II-211$100
   Simply Supplements Launches Glucosamine Supplements for Bone Health.....II-22
OXIS Launches ErgoFlex™ Dietary Supplements.....II-22
MonaVie Introduces MonaVie Active and MonaVie Original.....II-22
Forum Health to Launch Glucosamine Hydrochloride Supplement.....II-22
Nutramax Launches Start Cosamin® ASU Program.....II-22
1$100
   Schiff Nutrition Rolls Out Move Free® Advanced, the Next-generation Joint Care
  Product.....II-23
Nutrilite Unveils Glucosamine-7 for Better Joint Comfort in Shorter Period.....II-23
Promax Nutrition Launches Joint Xpress™.....II-23
1$100
   Cargill and The Elations Company to Introduce the Elations® Joint Health Supplement
  Beverages.....II-24
Triarco Launches Liquid Glucosamine.....II-24
Ethical Naturals Rolls Out GreenGrown Glucosamine.....II-24
Planet Nutrition Introduces Planet Nutrition Supplements Range.....II-24
1$100
   Pharma Base Introduces Osamine™ Pharmaceutical Grade Glucosamine.....II-25
Dr Organics Unveils Body Shot.....II-25
Navamedic Launches Mobilat Glucosamin.....II-25
Health Perception Launches GlucOsamax Extra.....II-25
Herbalife Unveils a Series of Anti-Aging Products Containing Glucosamine.....II-25
1$100
   Schiff Nutrition Launches New Move Free® Advanced.....II-26
Reno Introduces New Liquid Dietary Supplement.....II-26
Health Perception Launches ArheumaCare.....II-26
Neptune Technologies Introduces Glucosamine/NKO™.....II-26
BR Pharmaceuticals Reintroduces Valupak.....II-26
1$100
   Corwin Beverage to Distribute TandemRain’s Sports Rejuvenation Products.....II-27
Dee Pharma Signs Exclusive Permanent Distribution Deal with Laboratoires
  Expanscience.....II-27
Thai Union and Nippon Suisan Joint Venture to Manufacture Glucosamine.....II-27
Camlin Fine Chemicals to Foray into the US and European Markets.....II-27
Ethical Naturals and Cargill Reconciles Glucosamine Patent Dispute.....II-27
1$100
   Koyo Chemical to Expand Product Portfolio.....II-28
Bayer HealthCare Acquires OTC Business of Sagmel.....II-28
Hygieia Receives EU Approval for GlucosaGreen, a Vegetarian Glucosamine.....II-28
Navamedic Inks Agreement with Queisser Pharma.....II-28
1$100
   Lescarden Receives First Poly-NAG Order from Pascual Laboratories.....II-29
Navamedic Divests ChitiNor to Seagarden.....II-29
Navamedic Enters into a Deal with William Ransom.....II-29
Navamedic Signs Agreement with French Partner to Market Glucomed.....II-29
2$125
   Alcan Chemical Division (US).....II-31
Alfa Chem (US).....II-31
Cargill, Inc. (US).....II-31
1$100
   CMP Therapeutics Ltd. (UK).....II-32
Dalian Lijian Bio-Technology Development Co., Ltd (China).....II-32
Dalian Xindie Chitin Co., Ltd. (China).....II-32
Dee Pharmaceuticals Ltd (UK).....II-32
1$100
   Ethical Naturals, Inc. (US).....II-33
FabriChem, Inc. (US).....II-33
Golden-Shell Biochemical Co., Ltd. (China).....II-33
Koyo Chemical Company Limited (Japan).....II-33
Navamedic ASA (Norway).....II-33
1$100
   Nutraceutix, Inc. (US).....II-34
Nutramax Laboratories, Inc. (US).....II-34
NUTRILITE (US).....II-34
1$100
   Promax Nutrition Corporation (US).....II-35
Schiff Nutrition International, Inc. (US).....II-35
Shandong DongYing Development Zone Marine Biochemical Co., Ltd. (China).....II-35
1$100
   Shandong Jinan Haidebei Marine Bioengineering Co. Ltd. (China).....II-36
Simply Supplements (UK).....II-36
Synasia, Inc. (US).....II-36
Taizhou Candorly Sea Biochemical & Health Products Co., Ltd. (China).....II-36
1$100
   Triarco Industries, Inc (USA).....II-37
Xiamen Blue Bay Science & Technology Co., Ltd (China).....II-37
Zhejiang Freeman Shinfuda Co. Ltd. (China).....II-37
2$125
   Table 3: World Recent Past, Current & Future Analysis for Glucosamine by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-391$350
   Table 4: World Historic Review for Glucosamine by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-401$350
   Table 5: World 15-Year Perspective for Glucosamine by Geographic Region - Percentage Breakdown of Volume Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2003, 2010 & 2017 (includes corresponding Graph/Chart).....II-411$350
   A. Market Analysis.....II-42
Current and Future Analysis.....II-42
Arthritis: A Major Cause of Disability Among Elderly.....II-42
Glucosamine: A Good Fit for Joint Problems.....II-42
1$100
   Market Overview.....II-43
Key Trends & Issues.....II-43
Private Label Emerges as a Popular Choice Amid Recession.....II-43
Glucosamine Containing Products Grow in Number.....II-43
1$100
   Product Introductions.....II-443$150
   Strategic Corporate Developments.....II-471$100
   FOCUS ON SELECT PLAYERS.....II-484$175
   B. Market Analytics.....II-52
Table 6: The US Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-52
1$350
   Table 7: The US Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-531$350
   Market Analysis.....II-54
Table 8: Canadian Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-54
1$350
   Table 9: Canadian Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-551$350
   A. Market Analysis.....II-56
Strategic Corporate Development.....II-56
Koyo Chemical Company Limited – A Key Player.....II-56
1$100
   B. Market Analytics.....II-57
Table 10: Japanese Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-57
1$350
   Table 11: Japanese Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-581$350
   A. Market Analysis.....II-59
The United Kingdom: A High Growth Market for Vitamins, Minerals and
  Supplements.....II-59
Table 12: UK Market for Vitamins, Minerals, and Supplements (2007): Percentage Share Breakdown for Multivitamins, Fish Oils, Single Vitamins, Glucosamine, Evening Primrose & starflower Oils, Minerals, and Others (includes corresponding Graph/Chart).....II-59
1$350
   Table 13: UK Life Expectancy by Gender (1950-2020) (includes corresponding Graph/Chart).....II-60
Product Introductions.....II-60
1$350
   Strategic Corporate Developments.....II-611$100
   Focus on Select Players.....II-622$125
   B. Market Analytics.....II-64
Table 14: European Recent Past, Current & Future Analysis for Glucosamine by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-64
1$350
   Table 15: European Historic Review for Glucosamine by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-651$350
   Table 16: European 15-Year Perspective for Glucosamine by Geographic Region - Percentage Share Breakdown of Volume Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-661$350
   Market Analysis.....II-67
Table 17: French Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-67
1$350
   Table 18: French Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-681$350
   Market Analysis.....II-69
Table 19: German Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-69
1$350
   Table 20: German Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-701$350
   Market Analysis.....II-71
Table 21: Italian Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-71
1$350
   Table 22: Italian Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-721$350
   Market Analysis.....II-73
Table 23: The UK Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-73
1$350
   Table 24: The UK Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-741$350
   Market Analysis.....II-75
Table 25: Spanish Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-75
1$350
   Table 26: Spanish Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-761$350
   Market Analysis.....II-77
Table 27: Russian Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-77
1$350
   Table 28: Russian Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-781$350
   Market Analysis.....II-79
Table 29: Rest of Europe Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-79
1$350
   Table 30: Rest of Europe Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-801$350
   A. Market Analysis.....II-81
China - Poised to Become Major Glucosamine Consumer.....II-81
Arthritis in Australia.....II-81
Product Introductions.....II-81
1$100
   Focus on Select Players.....II-823$150
   B. Market Analytics.....II-85
Table 31: Asia-Pacific Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-85
1$350
   Table 32: Asia-Pacific Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-861$350
   Market Analysis.....II-87
Table 33: Rest of the World Recent Past, Current & Future Analysis for Glucosamine - Annual Sales Figures in Metric Tons for Years 2009 through 2017 (includes corresponding Graph/Chart).....II-87
1$350
   Table 34: Rest of the World Historic Review for Glucosamine - Annual Sales Figures in Metric Tons for Years 2003 through 2008 (includes corresponding Graph/Chart).....II-881$350
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com